odiparcil has been researched along with dalteparin in 1 studies
*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]
*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]
Studies (odiparcil) | Trials (odiparcil) | Recent Studies (post-2010) (odiparcil) | Studies (dalteparin) | Trials (dalteparin) | Recent Studies (post-2010) (dalteparin) |
---|---|---|---|---|---|
13 | 2 | 10 | 5,665 | 1,423 | 2,267 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eddington, ND; Khurana, M; Myers, AL; Upreti, VV | 1 |
1 trial(s) available for odiparcil and dalteparin
Article | Year |
---|---|
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aspirin; Chromatography, High Pressure Liquid; Drug Interactions; Enoxaparin; Female; Fibrinolytic Agents; Glycosaminoglycans; Glycosides; Humans; Liver Function Tests; Male; Middle Aged; Young Adult | 2008 |